Literature DB >> 18210213

A yeast model reveals biochemical severity associated with each of three variant alleles of galactose-1P uridylyltransferase segregating in a single family.

J S Chhay1, K K Openo, J S Eaton, M Gentile, J L Fridovich-Keil.   

Abstract

Classic galactosaemia is a potentially lethal inborn error of metabolism that results from profound impairment of galactose-1P uridylyltransferase (GALT). Like many autosomal recessive disorders, classic galactosaemia demonstrates marked allelic heterogeneity; many if not most patients are compound heterozygotes. Owing in part to the fact that most GALT mutations are never observed in patients in the homozygous state, in part to concerns of possible allelic interaction, and in part to the broad range of GALT activity levels associated with the affected, carrier, and control states, definition of the specific functional consequence of individual variant GALT alleles from studies of clinical samples alone can be a challenging task. To overcome this problem we previously developed and applied a null-background yeast system to enable functional analyses of human GALT alleles expressed individually or in defined pairs. We report here the application of this system to characterize three distinct variant alleles of GALT identified within a single family. Of these alleles, one carried a missense mutation (K285N) that has previously been reported and characterized, one carried a nonsense mutation (R204X) that has previously been reported but not characterized, and the third carried a missense substitution (T268N) that was novel. Our studies reported here reconfirm the profound nature of the K285N mutation, demonstrate that the R204X mutation severely compromises both expression and function of human GALT, and finally implicate T268N as one of a very small number of naturally occurring rare but neutral missense polymorphisms in human GALT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18210213     DOI: 10.1007/s10545-007-0786-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  24 in total

Review 1.  Structure and function of enzymes of the Leloir pathway for galactose metabolism.

Authors:  Hazel M Holden; Ivan Rayment; James B Thoden
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

2.  Heterodimer formation and activity in the human enzyme galactose-1-phosphate uridylyltransferase.

Authors:  J P Elsevier; L Wells; B B Quimby; J L Fridovich-Keil
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Overexpression, purification, and characterization of yeast cyclophilins A and B.

Authors:  L D Zydowsky; S I Ho; C H Baker; K McIntyre; C T Walsh
Journal:  Protein Sci       Date:  1992-08       Impact factor: 6.725

Review 4.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

5.  Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia.

Authors:  T M Wohlers; N C Christacos; M T Harreman; J L Fridovich-Keil
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

6.  Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast.

Authors:  Kerry L Ross; Charity N Davis; Judith L Fridovich-Keil
Journal:  Mol Genet Metab       Date:  2004 Sep-Oct       Impact factor: 4.797

7.  Interallelic complementation in hybrid cells derived from human diploid strains deficient in galactose-1-phosphate uridyl transferase activity.

Authors:  H L Nadler; C M Chacko; M Rachmeler
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

8.  A yeast expression system for human galactose-1-phosphate uridylyltransferase.

Authors:  J L Fridovich-Keil; S Jinks-Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

9.  Molecular and biochemical basis of galactosemia.

Authors:  B B Wang; Y K Xu; W G Ng; L J Wong
Journal:  Mol Genet Metab       Date:  1998-04       Impact factor: 4.797

10.  Identification and functional analysis of three distinct mutations in the human galactose-1-phosphate uridyltransferase gene associated with galactosemia in a single family.

Authors:  J L Fridovich-Keil; S D Langley; L A Mazur; J C Lennon; P P Dembure; J L Elsas
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

View more
  10 in total

1.  Altered cofactor binding affects stability and activity of human UDP-galactose 4'-epimerase: implications for type III galactosemia.

Authors:  Thomas J McCorvie; Ying Liu; Andrew Frazer; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2012-05-18

2.  A Case Study of Monozygotic Twins Apparently Homozygous for a Novel Variant of UDP-Galactose 4'-epimerase (GALE) : A Complex Case of Variant GALE.

Authors:  Ying Liu; Kristi Bentler; Bradford Coffee; Juliet S Chhay; Kyriakie Sarafoglou; Judith L Fridovich-Keil
Journal:  JIMD Rep       Date:  2012-07-01

3.  N- and O-linked glycosylation of total plasma glycoproteins in galactosemia.

Authors:  Ying Liu; Baoyun Xia; Tyler J Gleason; Uriel Castañeda; Miao He; Gerard T Berry; Judith L Fridovich-Keil
Journal:  Mol Genet Metab       Date:  2012-06-12       Impact factor: 4.797

4.  A frequent splicing mutation and novel missense mutations color the updated mutational spectrum of classic galactosemia in Portugal.

Authors:  Ana I Coelho; Ruben Ramos; Ana Gaspar; Cláudia Costa; Anabela Oliveira; Luísa Diogo; Paula Garcia; Sandra Paiva; Esmeralda Martins; Elisa Leão Teles; Esmeralda Rodrigues; M Teresa Cardoso; Elena Ferreira; Sílvia Sequeira; Margarida Leite; Maria João Silva; Isabel Tavares de Almeida; João B Vicente; Isabel Rivera
Journal:  J Inherit Metab Dis       Date:  2013-06-08       Impact factor: 4.982

5.  Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia.

Authors:  Thomas J McCorvie; Tyler J Gleason; Judith L Fridovich-Keil; David J Timson
Journal:  Biochim Biophys Acta       Date:  2013-04-11

6.  Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia.

Authors:  Emily L Ryan; Mary Ellen Lynch; Elles Taddeo; Tyler J Gleason; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2013-01-15       Impact factor: 4.982

7.  Modifiers of ovarian function in girls and women with classic galactosemia.

Authors:  Jessica B Spencer; Jennifer R Badik; Emily L Ryan; Tyler J Gleason; K Alaine Broadaway; Michael P Epstein; Judith L Fridovich-Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-20       Impact factor: 5.958

8.  Functional and structural impact of the most prevalent missense mutations in classic galactosemia.

Authors:  Ana I Coelho; Matilde Trabuco; Ruben Ramos; Maria João Silva; Isabel Tavares de Almeida; Paula Leandro; Isabel Rivera; João B Vicente
Journal:  Mol Genet Genomic Med       Date:  2014-06-23       Impact factor: 2.183

Review 9.  Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models.

Authors:  Minela Haskovic; Ana I Coelho; Jörgen Bierau; Jo M Vanoevelen; Laura K M Steinbusch; Luc J I Zimmermann; Eduardo Villamor-Martinez; Gerard T Berry; M Estela Rubio-Gozalbo
Journal:  J Inherit Metab Dis       Date:  2020-01-14       Impact factor: 4.982

10.  Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase.

Authors:  Thomas J McCorvie; Jolanta Kopec; Angel L Pey; Fiona Fitzpatrick; Dipali Patel; Rod Chalk; Leela Shrestha; Wyatt W Yue
Journal:  Hum Mol Genet       Date:  2016-03-22       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.